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CASE REPORT

Open Access

The value of early and comprehensive
diagnoses in a human fetus with
hydrocephalus and progressive obliteration
of the aqueduct of Sylvius: Case Report
Eduardo Ortega1, Rosa I. Muñoz2, Nelly Luza2, Francisco Guerra3, Monserrat Guerra2*, Karin Vio2, Roberto Henzi2,
Jaime Jaque1, Sara Rodriguez2, James P. McAllister4 and Esteban Rodriguez2

Abstract
Background: Mutant rodent models have highlighted the importance of the ventricular ependymal cells and the
subcommissural organ (a brain gland secreting glycoproteins into the cerebrospinal fluid) in the development of
fetal onset hydrocephalus. Evidence indicates that communicating and non-communicating hydrocephalus can be
two sequential phases of a single pathological phenomenon triggered by ependymal disruption and/or abnormal
function of the subcommissural organ. We have hypothesized that a similar phenomenon may occur in human
cases with fetal onset hydrocephalus.
Case presentation: We report here on a case of human fetal communicating hydrocephalus with no central
nervous system abnormalities other than stenosis of the aqueduct of Sylvius (SA) that became non-communicating
hydrocephalus during the first postnatal week due to obliteration of the cerebral aqueduct. The case was followed
closely by a team of basic and clinic investigators allowing an early diagnosis and prediction of the evolving
pathophysiology. This information prompted neurosurgeons to perform a third ventriculostomy at postnatal day 14.
The fetus was monitored by ultrasound, computerized axial tomography and magnetic resonance imaging (MRI).
After birth, the follow up was by MRI, electroencephalography and neurological and neurocognitive assessments.
Cerebrospinal fluid (CSF) collected at surgery showed abnormalities in the subcommissural organ proteins and the
membrane proteins L1-neural cell adhesion molecule and aquaporin-4. The neurological and neurocognitive
assessments at 3 and 6 years of age showed neurological impairments (epilepsy and cognitive deficits).
Conclusions: (1) In a hydrocephalic fetus, a stenosed SA can become obliterated at perinatal stages. (2) In the case
reported, a close follow up of a communicating hydrocephalus detected in utero allowed a prompt postnatal
surgery aiming to avoid as much brain damage as possible. (3) The clinical and pathological evolution of this
patient supports the possibility that the progressive stenosis of the SA initiated during the embryonic period may
have resulted from ependymal disruption of the cerebral aqueduct and dysfunction of the subcommissural organ.
The analysis of subcommissural organ glycoproteins present in the CSF may be a valuable diagnostic tool for the
pathogenesis of congenital hydrocephalus.
Keywords: Congenital hydrocephalus, Aqueduct of Sylvius, Cerebral aqueduct, Stenosis, Subcommissural organ,
Cerebrospinal fluid, Case study
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Background
Hydrocephalus is a condition in which cerebrospinal
fluid (CSF) accumulates within the brain ventricles,
resulting in ventricular dilatation and often increased
intracranial pressure [1]. It is now understood that
hydrocephalus is not only a disorder of CSF dynamics,
but also a brain disorder. The mechanistic views of
brain damage caused by increased intracranial pressure
do not answer the inborn and irreparable neurological
impairment of children with fetal onset hydrocephalus
[2–4]. Recent studies in mutant animals [5–7] and in
human hydrocephalic fetuses [8–12] have shown that
the loss of neural stem cells (NSC)/ependymal cells
forming the ventricular zone (VZ) during embryonic
development is associated with both hydrocephalus and
abnormal neurogenesis. The ventricular zone disruption leading to hydrocephalus and abnormal neurogenesis may result from gene mutations or environmental
factors, such as intraventricular hemorrhage or folic
acid deficiency [11]. Many gene mutations underlying
VZ disruption have been reported, all of them involved
in intracellular trafficking [12]. In addition, pathology
of the subcommissural organ (SCO), an ancient gland
secreting glycoproteins into the CSF, has been associated with the stenosis/obliteration of the aqueduct of
Sylvius (SA) and fetal onset hydrocephalus [13–19].
Here we describe the clinical and pathological evolution
of a patient that was diagnosed in utero with a progressive
obliteration of the SA and hydrocephalus and with abnormalities in SCO secretory proteins. The case was followed
by a multidisciplinary team that prompted neurosurgeons
to perform an early endoscopic third ventriculostomy.
The evidence collected indicates that such a surgery did
not resolve abnormalities in neurogenesis but completely
prevented secondary brain damage. This case illustrates
the importance of: (1) making an early diagnosis of fetal
hydrocephalus and closely following its evolution; (2) being aware of the probable mechanisms underlying the
transition from a mild communicating hydrocephalus to a
severe non-communicating hydrocephalus; and (3) being
conscious of the cellular mechanisms underlying the longterm neurological outcomes.
Case presentation
Clinical findings

An ultrasound (US) examination was performed at 28
gestational weeks (GW) on a woman aged 39 who had 3
previous pregnancies. Detailed two-dimensional (2D) and
three-dimensional (3D) US examinations were performed
with a scanner (Medison Model 8000) and a transabdominal transducer (2–5 MHz). It revealed a female fetus
with biometry consistent with 28 GW. A posterior US
confirmed the ventriculomegaly. Brain fetal biometry
parameters were as follows: biparietal diameter 7.51 mm,
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head circumference 295.6 mm, posterior horn of the lateral
ventricle width 19.3 mm. These parameters are in the
upper 90th percentile for gestational age and are suggestive
of ventriculomegaly. No other abnormal findings were obtained. Figure 1a shows the US performed at 36 GW, with
a lateral ventricle width of 22.3 mm. A follow-up magnetic
resonance imaging (MRI) examination performed at 33
GW revealed stenosis of the SA and ventriculomegaly, confirming hydrocephalus (Fig. 1b-d). At 37 GW, an elective
C-section was performed and a baby girl was delivered with
a weight of 2,750 g, a length of 45 cm (which is below the
10th percentile for gestational age), a cranial circumference
of 36.5 cm > P 98, and Apgar scores of 9 and 9 after 1 and
5 min, respectively. An examination of the neonate showed
a normal external morphology.
At postnatal day 2 a computerized axial tomography
study confirmed the large expansion of the third and lateral ventricles (Fig. 1e). The final diagnosis was fetal onset hydrocephalus. MRI performed on the 5th postnatal
day showed SA obliteration (Fig. 1f ). An endoscopic
third ventriculostomy was performed on the 14th postnatal day and ventricular CSF was collected. The penetration site of neuroendoscope was the prefrontal region
of the right hemisphere. Direct endoscopic visualization
from the third ventricle showed complete occlusion of
the SA. Since in animal models the subcommissural
organ (SCO) is involved in the SA stenosis/obliteration
[13–19], CSF samples were processed to study SCO
secretory proteins (see below). In the immediate postoperative period the patient developed ventriculitis and
fever prompting external ventricular drainage for ten
days and treatment with Ceftriaxone (100 mg/Kg/day)
and Vancomycine IV (10 mg/Kg/day). Following a good
response to antibiotic treatment the patient left the
Pediatrics Intensive Care Unit on the 60th postnatal day.
During the patient’s postnatal course, MRI and electroencephalography (EEG) studies, cognitive tests and CSF
analyses were performed. Parental informed consent and
approval from the Ethics Committees of the Universidad
Austral de Chile, Valdivia, Chile and the Hospital Regional
Valdivia, Chile, were obtained.
A MRI performed at 6 years of age showed obliteration of the SA, mild dilatation of the lateral ventricles,
a normal subarachnoid space, signs of periventricular
leukomalacia in the frontal horns of the lateral ventricles, and a zone suggesting a glial scar in the frontal subcortical zone (Fig. 2).
At 14 months of age the patient had an initial generalized
tonic-clonic seizure while she was sleeping (1:00–2:00 am).
Phenobarbital (6 mg/kg per day) was used as monotherapy
to treat the seizures with an adequate response. Subsequently, the patient had four additional tonic-clonic seizures during sleep, all of them associated with a decrease
of the Phenobarbital dose. The EEG study showed
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Fig. 1 Progressive obliteration of the aqueduct of Sylvius (SA) in hydrocephalus. a An ultrasound of the fetal patient at 36 GW demonstrating
dilation of the lateral ventricles (arrows). b MRI at 33 GW. The third ventricle (3°) and posterior horns of the lateral ventricles (ph) are dilated. c
MRI at 33 weeks. Stenosis of the SA is shown. d Detailed magnification of the area framed in C showing stenosis of the SA. 4°, fourth ventricle.
e CT at 39 GW (or the 2nd PN day). The lateral (LV) and third (3°) ventricles are dilated. f MRI of the brain on the 5th postnatal day, sagittal T2
imaging. The SA is obliterated

epileptiform specific activity in the posterior frontal region
with rapid intercritic generalization.
Psychomotor development

Her psychomotor development included sitting without
support during the 7th month, first intentional spoken
words during the 8th month, walking beginning during
the 17th month, and sphincter control by the 19th
month. At the 21st month the psychomotor development was evaluated as normal by using the Psychomotor
Development Test EEDP [20].

Neurocognitive assessment

The patient was examined by a clinical neuropsychologist at 3 and 6 years of age. During the 3rd year, a TEPSI
test aimed at the assessment of coordination, language
and motor development [20] was normal. However, a
discrepancy between the scales was evident; she excelled
in language but was below normal in coordination and
motor development. During the 6th year, a comprehensive neuropsychological test battery with a structured
interview was performed for several cognitive functions
aimed at the assessment of global cognitive functioning,
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Fig. 2 MRI findings at 6th years of age. a MRI (transverse T1 imaging) showing mild ventricular dilatation, a normal subarachnoid space (sas),
signs of periventricular leukomalacia (lk) in the frontal horns of the lateral ventricles, and a glial scar (gs) in the frontal subcortical zone. b, c MRI
(sagittal T1 and sagittal T2 imaging, respectively) showing complete obliteration of the SA

memory, language, processing speed, visual-spatial
abilities, and executive functions. The following tests
were used: Wechsler Intelligence Scale for Children
(WISC-R) [21, 22], Bender Visual Motor Gestalt Test
(BVMG) [23, 24], and Goodenough Test [25, 26].
Each valuation was performed in individual sessions.
According to the results of performance subtests (picture completion, block design, matrix reasoning and coding) of the WISC-R, the Intelligence Quotient (IQ) score
was normal (97). The patient had good verbal
conceptualization and language development accompanied by an appropriate numerical reasoning to age. She excelled on the Verbal Scale (112) but the Verbal Executive
scale was below the normal range (80); this discrepancy
was statistically significant (p >0.95), suggesting the existence of a neurological disorder. In addition, the patient
showed poor hand-eye coordination and an overall decreased maturation level, ranging from 5.0 to 5.1 years
old. She showed an appropriate long-term memory but diminished working and short-term memories, with serious
interference by hyperactivity, abnormal attention, and
concentration skills. She also had difficulties in abstract
thinking, synthesis and categorization. Concerning social
abilities, the patient had a very good deductive reasoning
and an adequate planning capacity, contrasting with her
diminished ability to cope and manage problems and situations of everyday life.
Molecular analysis

The subcommissural organ is phylogenetically the most
ancient brain gland, developing early in ontogeny [27, 28].
In the human it is fully developed by the 12th GW [28]. It
is located in the roof of the third ventricle at the entrance
of the SA (Fig. 3a, b). The SCO secretes into the CSF two
classes of proteins: the ones that remain soluble in the
CSF and consequently move with the flow of CSF and

those that aggregate to form an insoluble ever-growing
structure, the Reissner fiber [27–29]. SCO-spondin is the
main protein secreted by the SCO [30] and its complete
sequence was reported by Gobron et al. (2000) [31]. Proteins of 200, 63, 50, and 25 kDa reacting with antibodies
specific for SCO-spondin have been consistently found in
the CSF of normal rodents. These proteins most likely result from processing of SCO-spondin [32].
In the present case, immunoblot analyses of CSF collected at the time of endoscopic third ventriculostomy
were performed using antibodies against: (1) P15, a specific peptide whose sequence is unique for SCO-spondin
[28]; (2) a protein extract of human subcommissural
organ (anti-hSCO) [28]; (3) L1-CAM, an adhesion molecule that has been found in the CSF of hydrocephalic
newborns [33] and; (4) aquaporin-4 (anti-AQP-4), a
water channel selectively expressed by ependymal cells
and astrocytes [34–36]. Anti-P15 reacted with cells of
the SCO (Fig. 3b, inset). The pattern of anti-P15 reactive
compounds in the control CSF resembles that of the
CSF of normal rats [32]. The CSF in the present case
showed a pattern of anti-P15 reactive compounds different from that of historical controls; the compounds of
200 and 25 kDa were missing and an abnormal form of
180 kDa was present (Fig. 3c, d). The anti-hSCO also revealed differences between the CSF of the hydrocephalic
patient and that of control (Fig. 3e). The L1-CAM and
anti-AQP-4 were barely distinguished in the control CSF
but distinctly detected in the CSF of the hydrocephalic
patient (Fig. 4a, b).

Discussion
A Flecha chart summarizing key events of case report is
shown in the Fig. 5

On the basis of previous experimental evidence, the evolution of the patient reported was closely followed by a team
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Fig. 3 The human subcommissural organ (SCO). a Line drawing of a human brain showing the location of the SCO (red rectangle). b Sagittal section
through the epithalamus of a 32 GW human embryo (for orientation see rectangle in previous figure) showing the SCO, posterior commissure (pm),
pineal gland (P), third ventricle (3°) and SA. Inset. Ependyma of a human SCO (see frame in B), immunostained for SCO-spondin. Scale bar B 350 µm,
inset 50 µm. c Histograms of microdensitometric recordings of immunoblots with anti-P15, shown in (d). d Immunoblots of CSF samples from the
hydrocephalic case and from a 33rd GW fetus with an arachnoid cyst, using anti-P15 and anti-hSCO antisera. Blue arrows point to compounds present
in the hydrocephalic CSF and missing in the control; red arrows indicate compounds that are present in the control but missing or at lower
concentration in the hydrocephalic CSF. e Histograms of microdensitometric recording of immunoblots with anti-P15, shown in (d). Control, CSF
obtained by lumbar puncture from a patient 9 months old diagnosed with leukemia symptoms but no ventriculomegaly

of basic and clinic investigators, allowing an early diagnosis and confirmation of a predicted clinical and pathophysiological progression. In this case, an early postnatal
endoscopic third ventriculostomy was performed and at
six years of age the overall outcome of this child showed
only a minor neurological impairment. The evolution of a
communicating to a non-communicating hydrocephalus
should be considered when SA stenosis is diagnosed in
utero.
The clinical and pathological (imaging, neurocognitive
assessment, CSF analyses) evolution of the present patient
with fetal onset hydrocephalus supports the possibility
that the progressive stenosis of SA initiated during the
embryonic period may have resulted from (1) ependymal
disruption of the cerebral aqueduct and/or (2) dysfunction
of the subcommissural organ.
A strong body of evidence obtained in mutant hydrocephalic animals and human hydrocephalus indicates that

the loss of neural stem cells/ependyma from the embryonic
germinal zone, regarded as ventricular zone disruption, is
associated with the onset of hydrocephalus [5–12]. The disruption phenomenon is the final outcome of several genetic
and non-genetic abnormalities that lead to the abnormal
expression of gap and adherent junctions [11, 12, 37–39].
In mutant hyh mice, the time program of ventricular zone
disruption starts during fetal life and ends by the end of the
first postnatal week [5–7]. It is only after this disruption
program has been completed that the denuded walls of the
SA fuse and obliteration of the SA takes place, triggering
ventriculomegaly. Similar abnormalities of gap and adherent junctions have been also reported in the SA of full-term
hydrocephalic human fetuses [10–12]. In animal models,
environmental factors, such as intraventricular hemorrhage
or folic acid deficiency, as well as a long series of gene
mutations underlying the junction pathology of the ventricular zone preceding hydrocephalus have been reported
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Fig. 4 Proteins of ependymal cells are present in the hydrocephalic CSF. a Immunoblots of CSF samples from the hydrocephalic case and a
control using antibodies against L1-CAM) and AQP-4. The 180 kDa form of L1-CAM (red arrow and star) and other compounds reacting with
anti- L1-CAM are detectable in the hydrocephalic CSF but not in the control. The 35 kDa form of AQP-4 (red arrow and star) is readily detectable
in the hydrocephalic CSF but not in the control. b Histograms of microdensitometric recordings of immunoblots with anti- L1-CAM and
anti-AQP-4, shown in (a). Control, CSF obtained from a fetus with an arachnoid cyst, at 33rd GW

[1, 11, 12]. Although human hydrocephalic fetuses also display a junctional pathology of the ventricular zone, gene
mutations resulting in such a pathology have not yet been
identified [8]. In the case reported, no intraventricular
hemorrhage was detected, and deficiency of folic acid may
be ruled out since in Chile folic acid is included in the diet
through the wheat powder. Thus, it seems likely that in this
case the progressive SA stenosis, with no other neural tube
malformation, is associated with an as yet unknown gene
mutation.
The following evidence suggests that disruption of
the ependyma of the cerebral aqueduct may have
been part of the mechanism leading to SA stenosis
found in the present case: (1) hydrocephalus was
already detected at the 28th GW, with no other
apparent neural tube malformations; (2) stenosis of
the SA was detected at the 33rd GW and at the 3rd
postnatal day the SA was already obliterated, thus
resembling the time sequence found in mutant mice
(see above); (3) at six years of age, the SA continued
to be obliterated as expected from the lack of regeneration capacity of ependyma; (4) the presence in the
CSF, collected on the 14th postnatal day, of proteins

present in the plasma membrane of ependymal cells,
such as the L1 cell adhesion molecule and aquaporin
4, may reflect ependymal disruption [33–36].

The role of the subcommissural organ in fetal onset
hydrocephalus

A strong body of evidence indicates that the SCO plays
a key role in CSF flow and that its abnormal development in mutant animals leads to SA stenosis and
hydrocephalus [13–19]. There is evidence that the
negatively-charged SCO-spondin plays a key role in
keeping the SA open, and that its absence or its abnormal molecular forms trigger SA stenosis [13, 40–42].
The abnormal pattern of SCO-spondin-related polypeptides in the CSF of this case suggests that abnormalities
of the SCO were part of the mechanism leading to the
progressive stenosis of SA. In the hydrocephalic mutant
HTx rat the abnormal development of the SCO sequentially results in the secretion of abnormal forms of
SCO-spondin, SA obliteration and hydrocephalus [13].
It seems likely that this could also be the situation in
the present human case.

Ortega et al. BMC Neurology (2016) 16:45
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Fig. 5 Flecha chart of case report. Key events are summarized

Hydrocephalus and abnormal neurogenesis as a primary
pathology of neural stem cells/ ependymal cells

In mutant hydrocephalic animals and in humans with
fetal onset hydrocephalus, the disruption process of the
ventricular zone starts in the SA (see above) and spreads
to the telencephalon [5–12], where the disruption
phenomenon strikes the ventricular zone formed by
neural stem cells, resulting in several brain abnormalities. The most consistent abnormalities are: (1) loss of a
pool of neural stem cells and progenitor cells due to
their abnormal translocation into the CSF; and (2) formation of periventricular heterotopias due to abnormal
migration of neuroblasts [12, 39, 43, 44]. Periventricular
heterotopias behave as epileptogenic foci [45]. This may
explain why 6–30 % of hydrocephalic children, including
the present case, develop epilepsy that is not solved by
CSF drainage surgery [46–49]. Thus, the epilepsy and
the mild cognitive impairment developed by the patient
reported here could both be explained by a disruption of
the ventricular zone of the telencephalon. It may be proposed that in the present case the disruption of the

ependyma of the SA lead to hydrocephalus and a parallel
disruption of neural stem cells in the telencephalon results in a neurological impairment. A key distinction has
to be made between the inborn abnormal neurogenesis/
ependymogenesis and brain damage caused by hydrocephalus. Surgical treatments cannot resolve the former
but they could prevent further damage. Although unlikely, the possibility that the discrete damage to the
cerebral cortex caused during third ventriculostomy may
have long term outcomes, has to be considered. Indeed,
It is well substantiated that endoscopic third ventriculostomy results in a high rate (around 90 %) of good
long-term outcome in patients with obstructive hydrocephalus [50–52].

Conclusions
Three important messages should be remembered from
this case report: (1) make an early diagnosis of fetal
hydrocephalus and closely follow its evolution; (2) be
aware of the probable mechanisms underlying the transition from a mild communicating hydrocephalus to a
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severe non-communicating hydrocephalus; (3) be conscious of the cellular mechanisms underlying the longterm neurological outcomes.
Consent

Written informed consent for publication of this case report and accompanying images was obtained from the
mother of the patient. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.

Materials and methods
CSF collection

Case Patient: CSF was collected from a lateral ventricle
while endoscopic third ventriculostomy was performed
on the 14th postnatal day. Controls: (1) CSF obtained
from a fetus with an arachnoid cyst at the 33rd GW. (2)
CSF obtained by lumbar puncture from a 9 month old
patient diagnosed with leukemia symptoms. CSF samples
were centrifuged twice to remove cells or cell debris.
Samples were stored at −70 °C until analysis. Parental
informed consent and approval from the Ethics Committee of the Universidad Austral de Chile and Hospital Regional Valdivia, Chile, were obtained.
Immunoblotting

Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) was performed according to the Laemmli
method [53]. Briefly, 15 μl undiluted/non-concentrated
CSF samples were subjected to SDS-PAGE by using a 5 %–
15 % polyacrylamide linear gradient. Proteins were transferred to nitrocellulose membranes [54]. To block nonspecific binding, blots were saturated with 5 % non-fat milk in
0.1 M phosphate-buffered saline containing 0.15 mM NaCl
and 0.1 % Tween-20 (Sigma, Madrid, Spain), for 90 min.
The following antisera were used as primary antibodies: (1)
anti-P15 (rabbit polyclonal antibody raised against a unique
sequence of 15 aminoacids contained in SCO-spondin sequence [28]; 1:800 dilution); (2) anti-human SCO (rat polyclonal antibody raised against a protein extract of human
fetal SCO [28]; 1:800 dilution); (3) anti-L1-CAM (monoclonal antibody kindly provided by Dr. Vance Lemmon [55];
1:800 dilution); (4) anti-aquaporin 4 (rabbit polyclonal antibody; Sigma-Aldrich, USA;1:1500 dilution). Anti-rat or
rabbit IgG conjugated to horseradish peroxidase (Pierce,
Rockford, Ill., USA) was used at a 1:80,000 dilution, for
1.5 h. Incubations were carried out at room temperature in
the dark. Immunoreactive polypeptides were detected using
an enhanced chemiluminescence (ECL) system (Super
Signal; Pierce) as instructed by the manufacturer. Molecular
weight standards in the range of 10–250 kDa were used
(Bio-Rad, Hercules, Calif., USA). Control blots were processed as above, with no incubation in the primary antibody.
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